Showing results (211-220 of 276) with videos related to

Sort By:
Pageof 28
Hematological Oncology|May 31, 2020
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA groupYannick Le Bris, Florence Magrangeas, Anne Moreau, et al.
Haematologica|June 21, 2011
Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Société Française de Greffe de Moelle et de Thérapie CellulaireDamien Roos-Weil, Philippe Moreau, Hervé Avet-Loiseau, et al.
Haematologica|January 19, 2010
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie CellulaireAlice Garnier, Marie Robin, Fabrice Larosa, et al.
Blood|April 26, 2024
Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphomaClémentine Sarkozy, Mary Callanan, Catherine Thieblemont, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 25, 2026
Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T studyYassine Al Tabaa, Clément Bailly, Xavier Palard-Novello, et al.
Frontiers in Immunology|January 3, 2022
Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell LymphomaSimon Le Gallou, Faustine Lhomme, Jonathan M Irish, et al.
Transplantation and Cellular Therapy|July 10, 2021
Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease ProphylaxisMaxime Jullien, Corentin Orvain, Ana Berceanu, et al.
Haematologica|March 12, 2010
Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS groupRémy Gressin, Sylvie Caulet-Maugendre, Eric Deconinck, et al.
British Journal of Haematology|April 26, 2025
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA groupCharles Herbaux, Emmanuel Bachy, Reda Bouabdallah, et al.
Blood|April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemiaEric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
Pageof 28